文献速递肝胆胰外科

腹腔镜肝切除治疗肝细胞癌的长期结局:北美高容量中心的倾向性评分匹配分析

Long-term outcomes of laparoscopic liver resection for hepatocellular carcinoma: A propensity score matched analysis of a high-volume North American center.
PubMed 文献 · Surgery · 2021-11-03

该回顾性研究纳入2008年1月至2019年12月接受肝切除的肝细胞癌患者391例,经倾向性评分匹配后149例(腹腔镜57例,开腹92例)。腹腔镜组≥Clavien-Dindo III级并发症比例更低(14% vs 29%,P=0.01),两组1、3、5年总生存率和累积复发率无显著差异。

要点

  • 匹配后腹腔镜组≥Clavien-Dindo III级并发症为14%,开腹组为29%(P=0.01)。
  • 匹配后两组1、3、5年总生存率分别为90.9%、79.3%、70.5%与91.3%、88.5%、83.1%(P=0.26)。
  • 匹配后两组1、3、5年累积复发率分别为31.1%、59.7%、62.9%与18.9%、40.6%、49.2%(P=0.06)。

核心结论

  • 在可行情况下,腹腔镜入路兼具降低短期并发症和等效长期肿瘤学结局的优势。

研究设计与样本

  • 回顾性研究,纳入2008年1月至2019年12月接受肝切除的肝细胞癌患者391例(腹腔镜110例,开腹281例)。
  • 采用倾向性评分匹配患者人口学、实验室参数、肝病病因、肝功能和肿瘤特征,匹配后149例(腹腔镜57例,开腹92例)。

主要发现

  • 匹配后两组肝切除范围和肿瘤特征无显著差异。
  • 腹腔镜组≥Clavien-Dindo III级并发症比例低于开腹组(14% vs 29%,P=0.01)。
  • 匹配后腹腔镜组与开腹组1、3、5年总生存率分别为90.9%、79.3%、70.5%与91.3%、88.5%、83.1%(P=0.26)。
  • 匹配后腹腔镜组与开腹组1、3、5年累积复发率分别为31.1%、59.7%、62.9%与18.9%、40.6%、49.2%(P=0.06)。

临床怎么用

  • 作者认为,在可行情况下,腹腔镜入路因降低短期并发症且长期肿瘤学结局等效而更受青睐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic liver resections for malignancy are increasing worldwide, and yet data from North America are lacking. We aimed to assess the long-term outcomes of patients undergoing laparoscopic liver resection and open liver resection as a treatment for hepatocellular carcinoma. METHODS: Patients undergoing liver resection for hepatocellular carcinoma between January 2008 and December 2019 were retrospectively studied. A propensity score matching was performed using patient demographics, laboratory parameters, etiology of liver disease, liver function, and tumor characteristics. Primary outcomes included overall survival and cumulative incidence of recurrence. Kaplan-Meier and competing risk cumulative incidence were used for survival analyses. Multivariable Cox regression and Fine-Gray proportional hazard regression were performed to determine hazard for death and recurrence, respectively. RESULTS: Three hundred and ninety-one patients were identified (laparoscopic liver resection: 110; open liver resection: 281). After propensity score matching, 149 patients remained (laparoscopic liver resection: 57; open liver resection: 92). There were no significant differences between groups with regard to extent of hepatectomy performed and tumor characteristics. The laparoscopic liver resection group experienced a lower proportion of ≥Clavien-Dindo grade III complications (14% vs 29%; P = .01). In the matched cohort, the 1-, 3-, and 5-year overall survival rate in the laparoscopic liver resection versus open liver resection group was 90.9%, 79.3%, 70.5% vs 91.3%, 88.5%, 83.1% (P = .26), and the cumulative incidence of recurrence 31.1%, 59.7%, 62.9% vs 18.9%, 40.6%, 49.2% (P = .06), respectively. CONCLUSION: This study represents the largest single institutional study from North America comparing long-term oncologic outcomes of laparoscopic liver resection and open liver resection as a treatment for primary hepatocellular carcinoma. The combination of reduced short-term complications and equivalent long-term oncologic outcomes favor the laparoscopic approach when feasible.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Ivanics T, Claasen MP, Patel MS, et al. Long-term outcomes of laparoscopic liver resection for hepatocellular carcinoma: A propensity score matched analysis of a high-volume North American center. Surgery. 2021. PMID: 34742570. doi:10.1016/j.surg.2021.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。